News Industry News Medtronic Announces FDA Approval of Consulta® and Syncra™ Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Systems March 24, 2011
News Industry News Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich’s Genous™ Stent in Diabetic Patients March 23, 2011
News Industry News Advanced Cardiac Therapeutics Initiates First-In-Man CE Mark Clinical Trial to Study Innovative Catheter System for the Treatment of Atrial Arrhythmias March 17, 2011
News Industry News Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System March 06, 2011
News Industry News Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension February 22, 2011
News Industry News Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India February 16, 2011
News Industry News Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions February 14, 2011
News Industry News Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent January 25, 2011
News Industry News Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent January 23, 2011
News Industry News Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar January 18, 2011
News Industry News Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US January 04, 2011
News Industry News Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis January 04, 2011
News Industry News Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia January 02, 2011
News Industry News Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat